Info
Significant Ownership

Significant Ownership of K2 HealthVentures Equity Trust LLC

Signature - Title: /s/ Anup Arora - Anup Arora, Managing Member
Location: Boston, MA
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by K2 HealthVentures Equity Trust LLC.

Notify me when K2 HealthVentures Equity Trust LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of K2 HealthVentures Equity Trust LLC

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
TCRX	TScan Therapeutics, Inc.	Voting Common Stock, $0.0001 par value per share	6.9%	$5,764,320		3,602,700		K2 HealthVentures Equity Trust LLC	31 Dec 2024
NMRA	Neumora Therapeutics, Inc.	Common Stock, par value $0.0001 per share	5%	$19,253,655	-$5,136,588	8,997,035	-21%	K2 HealthVentures Equity Trust LLC	31 Dec 2025
ANRO	Alto Neuroscience, Inc.	Common Stock, $0.0001 par value per share	2.4%	$13,018,418	-$13,676,190	788,995	-51%	K2 HealthVentures Equity Trust LLC	31 Dec 2025

Schedules 13D/G Reported by K2 HealthVentures Equity Trust LLC:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.